Agilon Health Inc. (NYSE: AGL) reported Q4 EPS of ($0.41), $0.17 worse than the analyst estimate of ($0.24). Revenue for the quarter came in at $1.06 billion versus the consensus estimate of $1.02 billion.

GUIDANCE:

Agilon Health Inc. sees Q1 2024 revenue of $1.605-1.63 billion, versus the consensus of $1.596 billion.

Agilon Health Inc. sees FY2024 revenue of $6.35-6.42 billion, versus the consensus of $6.381 billion.

For earnings history and earnings-related data on Agilon Health Inc. (AGL) click here.